treatment of qooba (tinea cruris) with unani formulations

Phase 2

Not yet recruiting

• Conditions: Other specified local infections of the skin and subcutaneous tissue,

• Registration Number: CTRI/2020/03/023861
• Lead Sponsor: National Institute of Unani Medicine

Brief Summary

| |

| --- |

|Diagnosed cases of Tinea cruris fulfilling the inclusion criteria will be enrolled into clinical trial after obtaining written informed consent. All subjects will be given test drugs *Majoon-e-Shahtara* 7g orally twice daily with water (after meal) and *Zimad* for local application twice daily for 4 weeks, followed by  two weeks (35th and 42nd day) of post-trial follow ups for assessment of any relapse. Assessment of study outcome will be made on the basis of   observation of baseline and each follow up in the form subjective and objective parameters. The subjective parameters will be assessed with an arbitrary grading 4 – point Likert scale (where 0 = nil, 1 = mild, 2 = moderate and 3 = severe) accordingly objective parameters like photography of the lesions and KOH microscopy will be assessed on 0th (baseline) and on 4th week. Following two more follow ups will be made to assess any relapse of the trial effect.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2020-08-03
• Study Start: 2020-10-03

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Clinically and microscopically diagnosed patient of Tinea cruris Patient of either gender Age group 20-50 years Patient who have agreed to sign the informed consent form.

Exclusion Criteria

Patient below 20 years and above 50 years of age Pregnant and lactating women Patient with severe systemic and metabolic disorders Diabetic, HIV/AIDS or other immunocompromised patients Patient with concomitant skin disease like eczema and psoriasis Patient who are taking conventional medicine for Tinea cruris will be enrolled for the trial after a washed out period of 15 days.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement in subjective parameters	28 days

Secondary Outcome Measures

Name	Time	Method
Improvement in objective parameters	28 days

Trial Locations

Locations (1)

National Institute of Unani Medicine; 🇮🇳 Bangalore, KARNATAKA, India

National Institute of Unani Medicine

🇮🇳Bangalore, KARNATAKA, India

Mohammad Danish

Principal investigator

06307660289

mohddanish3189@gmail.com